GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 18.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $78,000 | +41.8% | 16,400 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $55,000 | +57.1% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $35,000 | -12.5% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $40,000 | +5.3% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $38,000 | +137.5% | 16,400 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $16,000 | -15.8% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $19,000 | -20.8% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $24,000 | +4.3% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $23,000 | +9.5% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $21,000 | -44.7% | 16,400 | 0.0% | 0.00% | -66.7% |
| Q3 2015 | $38,000 | -15.6% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $45,000 | -18.2% | 16,400 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $55,000 | -3.5% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $57,000 | -30.5% | 16,400 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $82,000 | – | 16,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $565,000 | 0.18% |
| D.A. DAVIDSON & CO. | 851,101 | $2,604,000 | 0.05% |
| Iron Gate Global Advisors LLC | 17,090 | $52,000 | 0.02% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $37,000 | 0.02% |
| IHT Wealth Management, LLC | 28,155 | $86,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,012,430 | $3,098,000 | 0.01% |
| Ameritas Investment Company, LLC | 10,782 | $33,000 | 0.01% |
| Vivaldi Capital Management LP | 15,439 | $40,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $48,000 | 0.01% |
| Geneos Wealth Management Inc. | 37,017 | $108,000 | 0.01% |